Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Molecular Partners Ag (MOLN) Other Operating Expenses: 2020-2025

  • Molecular Partners Ag's Other Operating Expenses was N/A to -$143.76 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.2 million, marking a year-over-year change of. This contributed to the annual value of $19.0 million for FY2021, which is 47.91% up from last year.
  • As of Q3 2025, Molecular Partners Ag's Other Operating Expenses stood at -$143.76, which was up 100.00% from -$3.2 million recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Other Operating Expenses ranged from a high of $19.0 million in Q4 2021 and a low of -$3.2 million during Q2 2025.
  • In the last 3 years, Molecular Partners Ag's Other Operating Expenses had a median value of -$71.88 in 2023 and averaged -$790,298.
  • In the last 5 years, Molecular Partners Ag's Other Operating Expenses soared by 48.97% in 2021 and then crashed by 84,853,763,449,799,904.00% in 2025.
  • Molecular Partners Ag's Other Operating Expenses (Quarterly) stood at $19.0 million in 2021, then reached -$0.00 in 2023, then reached -$0.00 in 2024, then slumped by 84,853,763,449,799,904.00% to -$143.76 in 2025.
  • Its last three reported values are -$143.76 in Q3 2025, -$3.2 million for Q2 2025, and -$0.00 during Q2 2024.